Get Our Top Trade Ideas Delivered Daily - 65% Off Now'
get this deal
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now'
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lonza Group
LZAGY
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$65.84
0.15
0.23%
At Close: -
15 minutes delayed
Get Report
Comment
Lonza Group (LZAGY) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Lonza Group (OTC:LZAGY) Stock
Lonza Group Stock (OTC: LZAGY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, March 20, 2024
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Vandana Singh
Wednesday, June 22, 2022
Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field
Vandana Singh
Wednesday, June 02, 2021
Moderna, Lonza Team Up To Produce New Drug Substance for COVID-19 Vaccine Doses
Vandana Singh
Thursday, April 29, 2021
Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually
Vandana Singh
Wednesday, April 14, 2021
aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810
Vandana Singh
Friday, March 12, 2021
Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza
Vandana Singh
Tuesday, February 23, 2021
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021
Benzinga Insights
JP Morgan Upgrades Lonza Group to Overweight
Benzinga Newsdesk
Tuesday, November 10, 2020
KeyBanc Initiates Coverage On Lonza Group wit...
Benzinga Newsdesk
Monday, July 27, 2020
Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development
Shivdeep Dhaliwal
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Thursday, February 13, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Wednesday, February 12, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Tuesday, February 11, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Wednesday, January 22, 2020
Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin
Tuesday, January 21, 2020
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Thursday, January 16, 2020
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
Thursday, October 17, 2019
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
Shanthi Rexaline
Mesoblast, Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast's Potential First United States Allogeneic Cell Therapy
Charles Gross
Tuesday, October 08, 2019
The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration
Shanthi Rexaline
Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
Charles Gross
Friday, August 09, 2019
A List Of Stocks Reaching New 52-Week Highs
Lisa Levin
Thursday, August 08, 2019
Stocks That Set New 52-Week Highs Thursday
Lisa Levin
Tuesday, July 23, 2019
Stocks that Broke 52-Week Highs Tuesday
Lisa Levin
Wednesday, June 19, 2019
Gamida Cell,Lonza Establish Commercial Manufacturing Agreement for Omidubicel
Charles Gross
Tuesday, July 17, 2018
Waters Has Limited Upside Potential To Growth Expectations; Janney Steps to The Sidelines
Benzinga
Thursday, April 14, 2016
Benzinga's M&A Chatter for Wednesday April 13, 2016
Benzinga
